Annual Cash & Cash Equivalents
$90.58 M
-$5.38 M-5.61%
31 December 2023
Summary:
Athira Pharma annual cash & cash equivalents is currently $90.58 million, with the most recent change of -$5.38 million (-5.61%) on 31 December 2023. During the last 3 years, it has risen by +$29.96 million (+49.42%). ATHA annual cash & cash equivalents is now -18.05% below its all-time high of $110.54 million, reached on 31 December 2021.ATHA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$68.86 M
-$4.97 M-6.73%
30 September 2024
Summary:
Athira Pharma quarterly cash and cash equivalents is currently $68.86 million, with the most recent change of -$4.97 million (-6.73%) on 30 September 2024. Over the past year, it has dropped by -$41.48 million (-37.59%). ATHA quarterly cash and cash equivalents is now -58.45% below its all-time high of $165.72 million, reached on 30 September 2020.ATHA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.6% | -37.6% |
| 3 y3 years | +49.4% | -35.9% |
| 5 y5 years | +2630.9% | - |
ATHA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -18.1% | +49.4% | -41.5% | at low |
| 5 y | 5 years | -18.1% | +4305.8% | -58.5% | +3249.0% |
| alltime | all time | -18.1% | +4305.8% | -58.5% | +3249.0% |
Athira Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $68.86 M(-6.7%) |
| June 2024 | - | $73.83 M(-5.1%) |
| Mar 2024 | - | $77.82 M(-14.1%) |
| Dec 2023 | $90.58 M(-5.6%) | $90.58 M(-17.9%) |
| Sept 2023 | - | $110.33 M(-2.9%) |
| June 2023 | - | $113.63 M(+8.0%) |
| Mar 2023 | - | $105.18 M(+9.6%) |
| Dec 2022 | $95.97 M | $95.97 M(+10.2%) |
| Sept 2022 | - | $87.05 M(-8.4%) |
| June 2022 | - | $95.06 M(-19.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $117.81 M(+6.6%) |
| Dec 2021 | $110.54 M(+82.3%) | $110.54 M(+3.0%) |
| Sept 2021 | - | $107.33 M(-18.5%) |
| June 2021 | - | $131.70 M(+3.0%) |
| Mar 2021 | - | $127.82 M(+110.8%) |
| Dec 2020 | $60.63 M(+2848.7%) | $60.63 M(-63.4%) |
| Sept 2020 | - | $165.72 M(+98.1%) |
| June 2020 | - | $83.67 M(+3969.4%) |
| Dec 2019 | $2.06 M(-38.0%) | $2.06 M |
| Dec 2018 | $3.32 M | - |
FAQ
- What is Athira Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Athira Pharma?
- What is Athira Pharma annual cash & cash equivalents year-on-year change?
- What is Athira Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Athira Pharma?
- What is Athira Pharma quarterly cash and cash equivalents year-on-year change?
What is Athira Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of ATHA is $90.58 M
What is the all time high annual cash & cash equivalents for Athira Pharma?
Athira Pharma all-time high annual cash & cash equivalents is $110.54 M
What is Athira Pharma annual cash & cash equivalents year-on-year change?
Over the past year, ATHA annual cash & cash equivalents has changed by -$5.38 M (-5.61%)
What is Athira Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ATHA is $68.86 M
What is the all time high quarterly cash and cash equivalents for Athira Pharma?
Athira Pharma all-time high quarterly cash and cash equivalents is $165.72 M
What is Athira Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, ATHA quarterly cash and cash equivalents has changed by -$41.48 M (-37.59%)